<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>

<title>Down With the Research Works Act. In the Pipeline: </title>

<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="description" content="">
<meta name="ICBM" content="42.341665, -71.078200" />
<meta name="DC.title" content="Corante: Boston" />
<!-- http://geourl.org/news/2005/02/25/launch.html -->

<!-- sitewide CSS -->

<link rel="stylesheet" href="http://www.corante.com/css/blogs.css" type="text/css" />
<link rel="stylesheet" href="http://pipeline.corante.com/local.css" type="text/css" />

<link rel="shortcut icon" href="http://www.corante.com/favicon.ico" type="image/ico" />

<!-- points to Feedburner.com -->
<link rel="alternate" type="application/rss+xml" title="RSS" href="http://pipeline.corante.com/index.xml" />

<!-- Site Javascript  CONSOLIDATE -->
<script src="http://www.corante.com/js/site_wide.js" language="javascript" type="text/javascript"></script>
<script src="http://www.corante.com/js/obfuscator.js" language="javascript" type="text/javascript"></script>

<script type="text/javascript">
var __MTTBLINK__;
var __MTTBID__;
function obfuscator(coded, key, mode, path, hidden) {
	shift = coded.length;
	link = "";
	
	for(i=0;i<coded.length;i++) {
		if (key.indexOf(coded.charAt(i))==-1) {
			ltr = coded.charAt(i);link+=(ltr);
		} else {
			ltr = (key.indexOf(coded.charAt(i)) - shift + key.length) % key.length;
			link += (key.charAt(ltr));
		}
	}
	if(mode == 'hidden_input') {
		document.write('<input type="hidden" name="CCode" value="' + link + '" />');
	} else if(mode == '__MTTBLINK__') {
		__MTTBLINK__ = path + link;
		if(hidden) return;
		document.write(link);
	} else if(mode == '__MTTBID__') {
		__MTTBID__ = link;
		if(hidden) return;
		document.write(link);
	}
}
</script>

<!-- RSS -->
<link rel="alternate" type="application/rss+xml" title="RSS" href="http://pipeline.corante.com/index.xml" />
<link rel="alternate" type="application/atom+xml" title="Atom" href="http://pipeline.corante.com/atom.xml" />
<link rel="EditURI" type="application/rsd+xml" title="RSD" href="http://pipeline.corante.com/rsd.xml" />

<script type="text/javascript" src="http://pipeline.corante.com/mt-site.js"></script>

</head>
<body>

<div id="aboutlinks">
<a href="http://www.corante.com/about.php">About Us</a> | <a href="http://www.corante.com/rss.php">RSS</a> | <a href="http://www.corante.com/adinfo.php">Advertise</a> | <a href="http://www.corante.com/contact.php">Contact Us</a>
</div>
<h1><a href="http://www.corante.com"><img src="http://www.corante.com/img/corante_head_logo2.gif" alt="Corante" width="233" height="37" border="0" /></a></h1>

<!-- NAVBAR -->

<table width="100%" cellpadding="0" cellspacing="0" border="0">
<tr><td class="sitenav" height="25"><a href="http://www.corante.com">Home</a> &gt; Weblog Columns &gt; <a href="http://pipeline.corante.com/">In the Pipeline</a></td><td class="sitenav" align="right"><form action="#">
<select
onchange="javascript:document.location=options[selectedIndex].value;"
class="archivemenu">
<option value="#">Weblog columns [select a blog]</option>
<option value="http://corante.corante.com/">[Corante Blog]</option>
<option
value="http://betweenlawyers.corante.com/">BETWEEN
LAWYERS: technology + culture + law</option>
<option value="http://brainwaves.corante.com/">BRAIN
WAVES:
neurons, bits  &amp; genes</option>
<option
value="http://copyfight.corante.com/">COPYFIGHT: the
politics of intellectual property</option>
<option value="http://goyami.corante.com/">GOYAMI: search engine marketing</option>
<option value="http://ideaflow.corante.com/">IDEAFLOW:
creativity
+ innovation</option>
<option value="http://pipeline.corante.com/">IN THE
PIPELINE: drug
discovery</option>
<option value="http://many.corante.com/">MANY-TO-MANY: social
software</option>
<option
value="http://rebuildingmedia.corante.com/">REBUILDING
MEDIA: the economics of media</option>
<option value="http://strange.corante.com/">STRANGE ATTRACTOR:
social media</option>
<option
value="http://totalexperience.corante.com/">TOTAL
EXPERIENCE: experience design</option>
</select>
</form></td><td width="9" align="right" style="background:url(http://www.corante.com/frontpage/crush_corner_etnaroc.gif) top right no-repeat;">
</td>
</tr>
<tr>
<td colspan="3">

<!-- SUB NAV/3 COLUMNS -->

<table width="100%" cellpadding="0" cellspacing="0" border="0" id="content">
<tr>
<td valign="top">

<div class="side">
<h5>About this Author</h5>

<img alt="DBL%20Hendrix%20small.png" src="http://pipeline.corante.com/DBL%20Hendrix%20small.png" width="115" height="199" />
College chemistry, 1983
<br>
<br>
<img src="http://www.corante.com/pipeline/dbl.jpg" alt="Derek Lowe" width="115" border="0" />
The 2002 Model
<br>
<br>
<img alt="Dbl%20new%20portrait%20B%26W.png" src="http://pipeline.corante.com/Dbl%20new%20portrait%20B%26W.png" width="115" height="144" />
After 10 years of blogging. . .
<br>
<br>
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. 
To contact Derek email him directly: <a href="mailto:derekb.lowe@gmail.com">derekb.lowe@gmail.com</a>
Twitter: Dereklowe<br>
<br>


<iframe src="http://rcm.amazon.com/e/cm?t=lagniappe-20&o=1&p=20&l=qs1&f=ifr" width="120" height="90" frameborder="0" scrolling="no"></iframe>
</div>

<div class="side">
Chemistry and Drug Data:
<a href="http://www.drugbank.ca/">Drugbank</a><br>
<a href="http://www.emolecules.com">Emolecules</a><br>
<a href="http://www.chemspider.com">ChemSpider</a><br>
<a href="http://lab.chempedia.com/">Chempedia Lab</a><br>
<a href="http://www.syntheticpages.org/">Synthetic Pages</a><br>
<a href="http://www.organic-chemistry.org/">Organic Chemistry Portal</a><br>
<a href="http://pubchem.ncbi.nlm.nih.gov/">PubChem</a><br>
<a href="http://chem.chem.rochester.edu/~nvd/index.html">Not Voodoo</a><br>
<a href="http://dailymed.nlm.nih.gov/dailymed/about.cfm">DailyMed</a><br>
<a href="http://www.druglib.com/">Druglib</a><br>
<a href="http://clinicaltrials.gov/">Clinicaltrials.gov</a><br>
<br>
Chemistry and Pharma Blogs:
<br>
<a href="http://orgprepdaily.wordpress.com/">Org Prep Daily</a><br>
<a href="http://cenblog.org/the-haystack/">The Haystack</a><br>
<a href="http://kilomentor.com/">Kilomentor</a><br>
<a href="http://anewmerckreviewed.wordpress.com/">A New Merck, Reviewed</a><br>
<a href="http://liberalchemistry.blogspot.com/">Liberal Arts Chemistry</a><br>
<a href="http://cenblog.org/just-another-electron-pusher/">Electron Pusher</a><br>
<a href="http://allthingsmetathesis.com/">All Things Metathesis</a><br>
<a href="http://cenblog.org/">C&E News Blogs</a><br>
<a href="http://luysii.wordpress.com/">Chemiotics II</a><br>
<a href="http://chemicalspace.wordpress.com/">Chemical Space</a><br>
<a href="http://baoilleach.blogspot.com/">Noel O'Blog</a><br>
<a href="http://invivoblog.blogspot.com/">In Vivo Blog</a><br>
<a href="http://cenblog.org/terra-sigillata/">Terra Sigilatta</a><br>
<a href="http://blogs.bbsrc.ac.uk/">BBSRC/Douglas Kell</a><br>
<a href="http://blog.chembark.com/">ChemBark</a><br>
<a href="http://realizationsinbiostatistics.blogspot.com/">Realizations in Biostatistics</a><br>
<a href="http://chemjobber.blogspot.com">Chemjobber</a><br>
<a href="http://www.pharmalot.com">Pharmalot</a><br>
<a href="http://www.chemspider.com/blog/">ChemSpider Blog</a><br>
<a href="http://pharmagossip.blogspot.com/">Pharmagossip</a><br>
<a href="http://synchemist.blogspot.com/">Med-Chemist</a><br>
<a href="http://organicchemistry-educationandindustry.blogspot.com/">Organic Chem - Education & Industry</a><br>
<a href="http://www.pharmastrategyblog.com/">Pharma Strategy Blog</a><br>
<a href="http://chem.vander-lingen.nl/">No Name No Slogan</a><br>
<a href="http://practicalfragments.blogspot.com/">Practical Fragments</a><br>
<a href="http://www.simbiosys.ca/blog/">SimBioSys</a><br>
<a href="http://ashutoshchemist.blogspot.com/">The Curious Wavefunction</a><br>
<a href="http://naturalproductman.wordpress.com/">Natural Product Man</a><br>
<a href="http://fbdd-lit.blogspot.com/">Fragment Literature</a><br>
<a href="http://www.rscweb.org/blogs/cw/">Chemistry World Blog</a><br>
<a href="http://syntheticnature.wordpress.com/">Synthetic Nature</a><br>
<a href="http://www.chemistry-blog.com/">Chemistry Blog</a><br>
<a href="http://syntheticorganic.blogspot.com/">Synthesizing Ideas</a><br>
<a href="http://mndoci.com/">Business|Bytes|Genes|Molecules</a><br>
<a href="http://www.eyeonfda.com">Eye on FDA</a><br>
<a href="http://chemicalforums.com/">Chemical Forums</a><br>
<a href="http://depth-first.com/">Depth-First</a><br>
<a href="http://blog.symyx.com/">Symyx Blog</a><br>
<a href="http://blogs.nature.com/thescepticalchymist/">Sceptical Chymist</a><br>
<a href="http://gaussling.wordpress.com/">Lamentations on Chemistry</a><br>
<a href="http://comporgchem.com/blog/">Computational Organic Chemistry</a><br>
<a href="http://miningdrugs.blogspot.com/">Mining Drugs</a><br>
<a href="http://www.ch.ic.ac.uk/rzepa/blog/">Henry Rzepa</a><br>
<br><br>
Science Blogs and News:
<br>
<a href=" http://www.badscience.net/">Bad Science</a><br>
<a href="http://phenomena.nationalgeographic.com/blog/the-loom/">The Loom</a><br>
<a href="http://scienceblogs.com/principles/">Uncertain Principles</a><br>
<a href="http://www.fiercebiotech.com/">Fierce Biotech</a><br>
<a href="http://dimer.tamu.edu/simplog/?blogid=3">Blogs for Industry</a><br>
<a href="http://omicsomics.blogspot.com">Omics! Omics!</a><br>
<a href="http://youngfemalescientist.blogspot.com/">Young Female Scientist</a><br>
<a href="http://williamtozier.com/slurry">Notional Slurry</a><br>
<a href="http://arstechnica.com/journals/science.ars">Nobel Intent</a><br>
<a href="http://www.scitechdaily.com/">SciTech Daily</a><br>
<a href="http://www.scienceblog.com/cms/index.php">Science Blog</a><br>
<a href="http://www.futurepundit.com/">FuturePundit</a><br>
<a href="http://scienceblogs.com/aetiology/">Aetiology</a><br>
<a href="http://www.gnxp.com">Gene Expression (I)</a><br>
<a href="http://blogs.discovermagazine.com/gnxp/">Gene Expression (II)</a><br>
<a href="http://www.sciencebase.com/science-blog/">Sciencebase</a><br>
<a href="http://scienceblogs.com/pharyngula/">Pharyngula</a><br>
<a href="http://scientopia.org/blogs/ethicsandscience/">Adventures in Ethics and Science</a><br>
<a href="http://www.transterrestrial.com">Transterrestrial Musings</a><br>
<a href="http://science.slashdot.org/">Slashdot Science</a><br>
<a href="http://blogs.discovermagazine.com/cosmicvariance/">Cosmic Variance</a><br>
<a href="http://www.biologynews.net/">Biology News Net</a><br>
<br><br>
Medical Blogs<br>
<a href="http://www.medrants.com/">DB's Medical Rants</a><br>
<a href="http://www.sciencebasedmedicine.org/">Science-Based Medicine</a><br>
<a href="http://www.gruntdoc.com/">GruntDoc</a><br>
<a href="http://scienceblogs.com/insolence/">Respectful Insolence</a><br>
<a href="http://www.diabetesmine.com/">Diabetes Mine</a><br>
<br><br>
Economics and Business<br>
<a href="http://www.marginalrevolution.com/">Marginal Revolution</a><br>
<a href="http://volokh.com/">The Volokh Conspiracy</a><br>
<a href="http://www.knowledgeproblem.com">Knowledge Problem</a><br>
<br><br>
Politics / Current Events<br>
<a href="http://www.dynamist.com/weblog/index.html">Virginia Postrel</a><br>
<a href="http://www.pajamasmedia.com/instapundit">Instapundit</a><br>
<a href="http://pajamasmedia.com/richardfernandez/">Belmont Club</a><br>
<a href="http://kausfiles.com/">Mickey Kaus</a><br>
<br><br>
Belles Lettres<br>
<a href="http://uncouthreflections.wordpress.com/">Uncouth Reflections</a><br>
<a href="http://www.aldaily.com">Arts and Letters Daily</a><br></td>
<td valign="top" width="100%">
<div class="bulletin"><div class="bulletin-background"><span class="bulletin-title">In the Pipeline:</span> Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at <strong><a href="http://pipeline.corante.com">In the Pipeline</strong></a></a></div></div>

<img src="http://www.corante.com/img/structural/spacecase.gif" border="0" width="350" height="1" />

<h2><a href="http://pipeline.corante.com/"><img class="blogtitle"  src="http://pipeline.corante.com/title.gif" alt="In the Pipeline" border="0" /></a></h2>

<div id="blog">
<div class="blogbody">

<p align="center">
<a href="http://pipeline.corante.com/archives/2012/01/16/defending_das_resvertrol_research_oh_come_on.php">&laquo; Defending Das' Resvertrol Research. Oh, Come On.</a> |

<a href="http://pipeline.corante.com/">Main</a>
| <a href="http://pipeline.corante.com/archives/2012/01/17/newhouse_research.php">Newhouse Research &raquo;</a>

</p>

<h4>
January 17, 2012
</h4>


<!--STANDARD ENTRY -->

<h3>Down With the Research Works Act</h3><span class="printemail"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#zemail"><img class="print" src="http://www.corante.com/frontpage/email.gif" alt="Email This Entry" border="0" /></a></span>

<p class="author">
Posted by <span class="authorname"></b>Derek</span>
</p>
<div class="img">
<p>Back in December, a short bill was introduced in the House called the "<a href="http://thomas.loc.gov/cgi-bin/query/z?c112:H.R.3699:">Research Works Act</a>". Its backers, Darrell Issa (R-CA) and Carolyn Maloney (D-NY), describe it as something that will maintain the US's standing in scientific publishing. After looking over its language and reading a number of commentaries on it, I have to disagree: this looks to me like shameless rent-seeking by the commercial scientific publishers.</p>

<p>And it pains me to say that, because I know several people in that business. But it's a business whose long-term model has problems. (See the Addendum below if you're not in the field and want a brief summary of how scientific publishing works). The problem is, the work of the editorial staff has changed a good deal over the years. Back when everyone sent in hard copies of papers, in who knows what sort of format, there was a good deal of work to do just turning the good ones into a consistent journal. Electronic submission has ironed a lot of the grunt work out - it's still work, but it's not what it used to be.</p>

<p>That leaves the higher editorial functions themselves, and here's where the arguing starts. <i>Most, and in some cases all editing of content is done by unpaid peer reviewers</i>. There are journals whose editors exist mainly to keep the flow of submissions moving to the reviewers, and from them back into the official journal, while hardly ever laying a finger on the copy itself. They function as Peer Review Mailroom Managers. And while that's a necessary job, it's the center of the argument about scientific publishing today. How much, exactly, is it worth?</p>

<p>Scientific journal are <i>expensive</i>. I mean, really, really expensive to subscribe to. And if you're not a subscriber, access to individual papers is pretty steep, too - typically in the $15 to $50 range. This is the business model for commercial scientific publishing: create a space with value (reputation, name recognition) and charge the maximum that that traffic will bear. And that's fine; there are a lot of businesses that work the same way - if they can.</p>

<p>The problem is, the information-sharing capabilities of the Internet blow a large hole in some of the traditional publishing model. And another problem is that a large number of papers that come into the journals from US academic researchers have had some (or all) of that work paid for by government grants (NIH, NSF, DOE and so on). As it stands, articles funded by the NIH are available in <a href="http://www.ncbi.nlm.nih.gov/pmc/">PubMed Central</a> for free access, no later (<a href="http://publicaccess.nih.gov/policy.htm">by law</a>) than 12 months from the initial journal publication. Researchers can also submit their work to "open access" journals (such as those from the <a href="http://www.plos.org/">Public Library of Science</a>), which charge a fee to authors to defray editorial costs, but then allow immediate unlimited access to all comers once a paper is accepted. (I should note that some commercial journals get away with "page charges" as well, and some have a model where the authors can <a href="http://en.wikipedia.org/wiki/Hybrid_open_access_journal">pay extra</a> to bring their paper out from behind the paywall).</p>

<p>And here's where we have the Research Works Act. It would forbid any publication in an open access journal for anything funded in academia by US government grants, and it would forbid any public-access repository for such work. That's its purpose. Well, to be more accurate, its purpose, as <a href="http://www.theatlantic.com/technology/archive/2012/01/why-is-open-internet-champion-darrell-issa-supporting-an-attack-on-open-science/250929/">described</a> by the head of the Association of American Publishers, is that it "ensures the sustainability of the industry". Yep, make my business model part of statutory law, and beggar my competition: what else is a government for, anyway?</p>

<p><i>Update: see the comments section. I'm interpreting the text of the law to mean the above, but another way to read it - probably the correct one - is that it's mainly rolling back the 2008 law that mandates that NIH-funded papers go open-access after a year. But that's bad enough as it stands.</i></p>

<p>To their credit, the MIT Press looks like the first big academic publisher <a href="http://poynder.blogspot.com/2012/01/mit-press-distances-itself-from.html">to defect</a> from this position. But the commercial publishers (Elsevier, Wiley, and so on) will never give up on this goal. Yes, the RWA, <a href="http://www.publishers.org/press/56/">according to them</a>, is aimed at "preventing regulatory interference with private-sector research publishers". Here's Congresswoman Maloney <a href="http://www.michaeleisen.org/blog/?p=846">using Elsevier's own press release language</a>, sentence by sentence, as detailed by Michael Eisen, co-founder of PLoS. (He also has <a href="http://www.nytimes.com/2012/01/11/opinion/research-bought-then-paid-for.html?_r=1">an op-ed</a> in the <i>New York Times</i> on this issue).</p>

<p>I see no reason why we should make the current scientific publishing system a matter of law. I think it should change - and be allowed to change - as new technology allows it to. And I think that the Research Works Act is nothing more a blatant attempt to hold on to a profitable business plan. </p>

<p><i>Addendum: For those outside the scientific world, here's a brief summary of how things have traditionally worked. As a scientist (academic or industrial), you take the time and effort to write up your results for a journal. You have to pick your journal at the start of the process, since each of them have their own ways of organizing a paper, their own preferred way of citing other papers as references, and so on. Anyone can send anything to any journal they feel like, although you'd be well advised to target your paper to the ones that (a) have the best chance to actually accept it and (b) will do you good to have a paper published in. The overlap between those two may not be large, or may not exist at all, depending on your paper. These days, most journals have templates for Word or the like, which standardizes the submissions, and have some sort of automatic PDF generation during the submission step step so you can see how the paper will look when formatted in the journal's style and page layout.</p>

<p>Your manuscript is given a quick check to make sure that it's appropriate for review. A few of of the higher-end journals make this a key step, because they can afford to turn down even rather interesting papers as not necessarily worth their time to go on checking. But in most journals, unless there's something obviously off, your paper goes out for peer review. Two or more scientists from Out There Somewhere look it over and send in comments. Those comment forms have a section for the original authors to see, and a section for remarks that go just to the editorial staff, and you can use those as you see fit. (I, for example, once used the latter forum to ask the editors to please stop sending me papers from a certain author, because I'd done three of them and couldn't stand to see any more. They honored my request.)</p>

<p>As an author, you see the comments when they come back and get a recommendation from the journal - usually it's "Publish as is", "Publish after minor revisions", "Publish after major revisions", or "Go away". That last one usually isn't expressed in quite those words. The middle two are the most common, since most stuff eventually gets published somewhere if the authors are persistent enough (and are willing enough to have their work appear in the <i>Zambodian Journal of Chemistry</i> or what have you).</p>

<p>Now at this point, traditionally, the work of assembling the accepted papers into a printed journal kicks in on the editorial side. And it still does, but that process is becoming less and less important. I honestly can't tell you when I last saw a hard copy of any of the journals I read regularly. Even the idea of separate issues is becoming antiquated, since new papers (in the case of many journals) just plop out onto the web site (and into the RSS feeds) as they emerge from the review process.</i></p>
<a name="more"></a>
</div>


<p class="posted">
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#comments">Comments (35) </a>
</MTEntryIfAllowComments>+ <a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#comments">TrackBacks (0)</a> | Category: <a href="http://pipeline.corante.com/archives/the_scientific_literature/">The Scientific Literature</a> 
</p>



<!-- BLINK -->



<!-- SPONSORED POST -->


 


<br />

<!-- COMMENTS DISPLAY -->




<div class="comments">
<a name="comments"></a><b>COMMENTS</b>
<div id="commentflip">
<p class="commentsbody"><a name="747076"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747076">1. </a></span><span style="color:#036">Lars Ambach </span> on January 17, 2012  9:44 AM writes...</p>
<p>This bill is a horrible, horrible idea. The very notion that publicly funded research results should be available through commercial publishers only is offensive to me.</p>

<p>Mandatory open access for people who get funded by gov grants is the very least. You get tax money, you show what you did with it to the tax payers (even if only a small percentage is interested in what you actually do). Simple as that.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747076">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="747087"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747087">2. </a></span><span style="color:#036">PharmaHeretic </span> on January 17, 2012  9:48 AM writes...</p>
<p>Publishing is the one aspect of modern science which is even more scam ridden than the stuff it publishes. OK, peer review as we know it is almost as bad- but that raises a bigger question.</p>

<p>How can an enterprise that runs on pedigree, abuse of its workers, dogma, groupthink, delusions, scams and reviews its work through equally scummy people to publish in rent-seeking journals discover scientific truth other than by accident?</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747087">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="747097"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747097">3. </a></span><span style="color:#036">Winston Churchill </span> on January 17, 2012  9:49 AM writes...</p>
<p>This bill is yet another example of why campaign finance reform is so necessary. True democracy in the best interest of the people cannot exist when politicians are up for sale. </p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747097">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="747101"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747101">4. </a></span><span style="color:#036">Virgil </span> on January 17, 2012  9:52 AM writes...</p>
<p>I have already written my member of congress (Louise Slaughter) asking her to oppose the bill, and to look more deeply into the "coincidence" that its co-sponsor just happens to hold the congressional seat for NYC, where all the big publishers have their offices.  I would encourage everyone to do the same.</p>

<p>Another "coincidence"... this bill was introduced the very same week that the OSTP closed down its request-for-information on the future of public access.  Publishers were lobbying heavily with academics to have them submit pro-journal viewpoints to this RFI.  The bill (HR3699) appears to be a thinly veiled attempt to get some legislation on the books before the inevitable results of that RFI are made public.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747101">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="747104"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747104">5. </a></span><span style="color:#036"><a href="http://orgprepdaily.wordpress.com" rel="nofollow">milkshake</a> </span> on January 17, 2012  9:53 AM writes...</p>
<p>it reminds me the Adam Smith quote: "As soon as the land of any country has all become private property, the landlords, like all other men, love to reap where they never sowed, and demand a rent even for its natural produce."<br />
</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747104">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="747117"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747117">6. </a></span><span style="color:#036">Bender </span> on January 17, 2012 10:01 AM writes...</p>
<p>I'd like to know what Rudy Baum thinks of this, considering he is a strong opponent of open access, yet recently wrote an editorial lambasting the government for trying to suppress access to research on man-made flu viruses.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747117">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="747118"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747118">7. </a></span><span style="color:#036">MTK </span> on January 17, 2012 10:01 AM writes...</p>
<p>Politics as usual as they say.</p>

<p>Wasn't it Rick Santorum while a Senator that introduced a bill that would have prohibited the National Weather Service from making, well, weather predictions?  It was, of course, coincidental that Accu-Weather is located in State College, PA and contributed to his campaign.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747118">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="747126"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747126">8. </a></span><span style="color:#036">zmil </span> on January 17, 2012 10:08 AM writes...</p>
<p>" It would forbid any publication in an open access journal for anything funded in academia by US government grants..."</p>

<p>While I think the law is a terrible, horrible, very bad idea, I don't think this is accurate, from my reading of the law. It forbids the gov't from *requiring* open access to federally funded research papers, but it does not forbid open access publication of said research.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747126">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="747175"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747175">9. </a></span><span style="color:#036">RickW </span> on January 17, 2012 10:30 AM writes...</p>
<p>Thanks for this post. I've never been as big of a supporter of open access journals as some others, since getting a good faculty position in biology still means having Cell/Science/Nature papers as a postdoc. This law, however, is really outrageous. I second the comment above about campaign finance reform. I can't think of another bill or law that is more blatantly bought and paid for without any public benefit. </p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747175">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="747223"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747223">10. </a></span><span style="color:#036">Anonymous </span> on January 17, 2012 10:53 AM writes...</p>
<p>Look up the definition of Fascism.  This bill fits it perfectly.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747223">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="747225"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747225">11. </a></span><span style="color:#036">johnnyboy </span> on January 17, 2012 10:54 AM writes...</p>
<p>Campaign finance reform ? Ha ! There's just been one rather large campaign finance reform last year, in the form of the Supreme Court's Citizens United ruling. The supremes basically handed over the political system on a silver platter to large corporations. As long as the court is dominated by republicans, you can expect more and more of such 'pay to play' laws, not fewer.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747225">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="747298"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747298">12. </a></span><span style="color:#036">Honclbrif </span> on January 17, 2012 11:41 AM writes...</p>
<p>Holy crap. I've never written to my congressman before, but I just did.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747298">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="747316"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747316">13. </a></span><span style="color:#036">Winston Churchill </span> on January 17, 2012 11:54 AM writes...</p>
<p>Honclbrif, did you include a check with your letter?</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747316">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="747341"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747341">14. </a></span><span style="color:#036">pete </span> on January 17, 2012 12:11 PM writes...</p>
<p>@13 Winston<br />
"..did you include a check with your letter?"<br />
I'd venture that if you could follow the money on this bill, you'd find significant quid pro quo ($$$) going from the publisher's accounts ==> Issa- & Maloney-related accounts.<br />
</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747341">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="747347"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747347">15. </a></span><span style="color:#036"><a href="http://www.pathophilia.com" rel="nofollow">bmartinmd</a> </span> on January 17, 2012 12:15 PM writes...</p>
<p>While I'm certainly no legal scholar, I wonder if the bill itself is completely unconstitutional (ie, anti-First Amendment). That said, I'm constantly irritated that the published results of any medical or scientific research funded in whole or in part by taxpayer money is not made immediately and freely accessible (bugger 12 months).</p>

<p>However, I would heartily disagree with the notion that editorial services (at least at some scientific/medical journals) are largely pro forma these days. Copy editors, in particular, perform a tremendous amount of work mechanically and stylistically reshaping submitted articles into something approaching comprehension. In my experience working at an unnamed medical journal, submitted articles were largely in unpublishable English (including those by UK and American authors), and peer reviewers submitted only suggestions or recommendations for high-level content changes. They certainly did not perform any heavy lifting in terms of editing or frankly rewriting an entire article so that it was actually readable and understandable. That job was left to the editors, and specifically woefully underpaid copy editors. The painful quality of first-draft writing by physicians and scientists hasn't and won't change merely because we're in the electronic age. Sadly.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747347">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="747493"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747493">16. </a></span><span style="color:#036">William Penrose </span> on January 17, 2012  2:07 PM writes...</p>
<p>So who's surprised? Congress is blatantly up for sale, and will be for some time to come. If I were earning the fat profits commercial publishers rake it, I'd do whatever to protect it. <br />
</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747493">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="747525"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747525">17. </a></span><span style="color:#036"><a href="http://pipeline.corante.com" rel="nofollow">Derek Lowe</a> </span> on January 17, 2012  2:24 PM writes...</p>
<p>#8 Zmil - here's the text:</p>

<p>       No Federal agency may adopt, implement, maintain, continue, or otherwise engage in any policy, program, or other activity that--</p>

<p>            (1) causes, permits, or authorizes network dissemination of any private-sector research work without the prior consent of the publisher of such work; or</p>

<p>            (2) requires that any actual or prospective author, or the employer of such an actual or prospective author, assent to network dissemination of a private-sector research work.</p>

<p>The second part is what you address, that no one could require open access. But the first part is what I was thinking of. "Without the prior consent of the publisher of said work", which isn't going to happen, "No Federal agency", which means all the granting agencies, can permit any private-sector work (their grant recipients) to be open-access.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747525">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="747545"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747545">18. </a></span><span style="color:#036">zmil </span> on January 17, 2012  2:38 PM writes...</p>
<p>"'Without the prior consent of the publisher of said work', which isn't going to happen..."</p>

<p>Unless you publish in an open access journal.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747545">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="747711"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747711">19. </a></span><span style="color:#036"><a href="http://pipeline.corante.com" rel="nofollow">Derek Lowe</a> </span> on January 17, 2012  5:13 PM writes...</p>
<p>But I wonder if that second clause even permits anyone with NIH money (or any other government grant) to publish in an open-access journal at all? After all, by publishing in one, that "requires that you assent to network dissemination". Otherwise, what does an open-access journal require you to do?</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747711">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="747744"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747744">20. </a></span><span style="color:#036">zmil </span> on January 17, 2012  5:33 PM writes...</p>
<p>Maybe I'm parsing the lawyerese wrong, but I think the second clause "requires" refers to the Feds, not the publishers. Basically, they can't require Fed-funded research be published in open-access journals. And, from the first clause, they can't permit dissemination of non-open access papers. </p>

<p>Without the second clause the first clause would let the NIH require that all NIH-funded research be published in PLoS or some such, kind of the opposite of what Elsevier and friends want...</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747744">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="747750"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747750">21. </a></span><span style="color:#036">Will </span> on January 17, 2012  5:38 PM writes...</p>
<p>here's how i read the two clauses</p>

<p>the first clause repeals the current rule by the NIH that after one year, NIH funded research must be made publicly available.  Instead, the publisher (eg, elsevier/acs) must give consent to disseminate the work, regardless of how old it is</p>

<p>the second clause recognizes that the NIH may try to go around the first, and thus prohibits the NIH from requiring that funded research be published in a freely available format (eg PLoS).  the law doesn't prevent an indvidual from choosing to publish in PLoS, it just can't force him/her to do it.  </p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747750">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="747755"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747755">22. </a></span><span style="color:#036">Will </span> on January 17, 2012  5:43 PM writes...</p>
<p>along a slightly different line, i've noticed that at least one big name in academic organic, dave evans, has direct links to all his publications in pdf format</p>

<p>presumably acs/elsevier doesn't like this - how does he get away with it?</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747755">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="747776"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747776">23. </a></span><span style="color:#036">A different Derek </span> on January 17, 2012  6:07 PM writes...</p>
<p>The devil's in the definitions (Section 3 of the law).<br />
A "private-sector research work" is defined more-or-less as an article *submitted to a journal* (the language is "intended to be published in a scholarly or scientific publication . . . and to which a commercial or nonprofit publisher has made or has entered into an arrangement to make a value-added contribution, including peer review or editing").<br />
So the first part of the operative part of the Act, Section 2, quoted by Derek Lowe at 17, would inter alia prohibit the current NIH practice of requiring their grantees' articles be available for free access after 1 year *unless the publisher agreed* (fat chance, unless the journal is open-source), while the second part would prevent granting agencies from requiring grantees to agree to open-source dissemination of their submitted articles.<br />
Thus, as I understand it, grantees could submit to open-source journals, but if they choose to submit to, say, an Elsevier journal, the sponsoring agency can't make the article open-source without Elsevier's consent, nor can it require the grantee to agree that the article become open-source. </p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747776">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="747790"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747790">24. </a></span><span style="color:#036">A different Derek </span> on January 17, 2012  6:13 PM writes...</p>
<p>Le me rewrite my last sentence from 23:</p>

<p>Thus, as I understand it, grantees can submit to open-source journals if they wish but the granting agency can't make them do so (part 2 of Section 2); and if they do submit to, say, an Elsevier journal, the granting agency can't make the article open-source without Elsevier's consent (part 1)</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747790">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="747834"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747834">25. </a></span><span style="color:#036">Martin </span> on January 17, 2012  6:42 PM writes...</p>
<p>Haven't seen this mentioned here in the comments but one things that does strike me (as an non-US citizen, living outside the US) about this bill is that it would appear to also be a token means to stop those underpaid overworked labworkers in Zambodia or anywhere to profit from the toils of US citizens paid for by the US taxpayer. Or am I reading too much?</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#747834">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="748063"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#748063">26. </a></span><span style="color:#036">Mutant Dragon </span> on January 17, 2012 10:05 PM writes...</p>
<p>This is a downright joke. Journal subscriptions cost an arm and a leg and yet most of the real editing is done gratis, as you point out. So why on Earth do we need the government to grant the traditional publishers a monopoly? I personally think it's ludicrous that the published results of research that the taxpayer funded are not freely available to said taxpayer as it is. I would dearly love to know what prompted said Congresscritters to introduce this ridiculous excuse for a piece of legislation.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#748063">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="748112"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#748112">27. </a></span><span style="color:#036">Dan </span> on January 17, 2012 11:00 PM writes...</p>
<p>I don't read the quoted section the same way, Derek. It looks to me like Will and the other Derek have it right: the bill would not forbid the author from submitting to an open-access publication, but it would guarantee that they cannot be _required_ to do so and that the federal agency cannot resubmit the paper to an open-access publication.</p>

<p>(I wonder, though ... is the "publisher of such work" defined as the journal in which it's published, or the author of the paper? Legalese is a language all its own.)</p>

<p>I think that's still a mistake (publicly funded research ought to be publicly available, period, unless we're talking military-classified stuff), but it's less of a mistake than actually forbidding it.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#748112">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="748117"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#748117">28. </a></span><span style="color:#036">Hibob </span> on January 17, 2012 11:05 PM writes...</p>
<p>Universities are tired of being cash cows for Elsevier et ilk; there's certainly no love lost between the U of C and Nature Publishing Group.</p>

<p>Who wants to bet that other universities will follow MIT and adopt a licensing model that reserves open access copyright on all of their faculties' manuscripts?</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#748117">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="748149"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#748149">29. </a></span><span style="color:#036">Anonymous Academic </span> on January 17, 2012 11:35 PM writes...</p>
<p>I agree with zmil/Will/Dan - nothing I've read suggests that the bill would actually prohibit publishing in an open-access journal (which would be truly wretched even by the low, low standards of the US Congress).  The actual intent is bad enough, and a blatant attempt to preserve an obsolete business model, but it's not actually trying to put the competition out of business.</p>

<p>@Hibob: universities may be tired of the big publishers, but the faculty are still pretty spineless - how many UC professors (aside from Michael Eisen) do you think would pass up publication in Nature just to stand on principle?</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#748149">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="748187"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#748187">30. </a></span><span style="color:#036">zmil </span> on January 18, 2012 12:18 AM writes...</p>
<p>@Will</p>

<p>"along a slightly different line, i've noticed that at least one big name in academic organic, dave evans, has direct links to all his publications in pdf format</p>

<p>presumably acs/elsevier doesn't like this - how does he get away with it?"</p>

<p>I believe this is generally accepted practice; researchers have always had the right to give out copies of their papers. Putting links on the web goes a little farther than that, but I've seen it reasonably often, and I think the publishers don't mind too much. Not sure, though.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#748187">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="749375"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#749375">31. </a></span><span style="color:#036">Wilson </span> on January 18, 2012 12:54 PM writes...</p>
<p>So what's the position of the American Chemical Society on this issue?</p>

<p>I can guess. </p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#749375">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="749463"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#749463">32. </a></span><span style="color:#036"><a href="http://depth-first.com" rel="nofollow">Rich Apodaca</a> </span> on January 18, 2012  2:13 PM writes...</p>
<p>Derek, you're usually right on target, but you should have read up more before writing about this issue. Not only do you get some of the facts wrong (as your revisions indicate), but I think you've failed to consider the bigger picture.</p>

<p>See this for an alternative perspective:</p>

<p><a href="http://bit.ly/wVQXYL" rel="nofollow">http://bit.ly/wVQXYL</a></p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#749463">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="749934"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#749934">33. </a></span><span style="color:#036">Eric Jablow </span> on January 18, 2012  7:18 PM writes...</p>
<p>For a very thoughtful look at the world of academic publishing, you might want to look at Donald Knuth's letter to the editorial board of the Journal of Algorithms about their dispute with Elsevier.  After all, you and your publishers are probably using his software.</p>

<p><a href="http://www-cs-faculty.stanford.edu/~knuth/joalet.pdf" rel="nofollow"><a href="http://www-cs-faculty.stanford.edu/~knuth/joalet.pdf" rel="nofollow">http://www-cs-faculty.stanford.edu/~knuth/joalet.pdf</a></a></p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#749934">Permalink to Comment</a> 
</p>
</div>
<div id="commentflop">
<p class="commentsbody"><a name="755497"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#755497">34. </a></span><span style="color:#036">hibob </span> on January 22, 2012  7:00 PM writes...</p>
<p>@AA#29:<br />
Whether or not UC professors would stand on principle as individuals, the UC system as a whole was working on an MIT style open access policy back in '07. They dropped it after the NIH open access policy solved some of the issues.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#755497">Permalink to Comment</a> 
</p>
</div>
<div id="commentflip">
<p class="commentsbody"><a name="771250"></a><span class="commentnumber"><a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#771250">35. </a></span><span style="color:#036">Jim A </span> on February  3, 2012 10:47 AM writes...</p>
<p>Keep in mind that the publishers are perfectly free to decline to publish works covered by the NIH mandate.  No government agency is forcing them to do anything.  But it seems that free is too much to pay to get one year of exclusive access to government funded research.  So THEY don't think that the editing that they provide is valuable enough that they can simply decline to publish research funded by NIH.  It would be like a factory trying to lockout unpaid volunteers...Instead they want a law mandating that they will have exclusive rights to the research for the near-infinite copyright term.</p>

<p>It's similar to the WIPO broadcast treaty in an attempt to preserve or create copyright or copyright-like rights for the distributers rather than the creators of content.</p>
<a href="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php#771250">Permalink to Comment</a> 
</p>
</div>

</div>



<!-- TRACKBACKS DISPLAY -->





<!-- POST A COMMENT -->


<b>POST A COMMENT</b>

 



<form method="post" action="http://www.corante.com/cgi-bin/mt/terioria.fcgi" name="comments_form" onsubmit="if (this.bakecookie[0].checked) rememberMe(this)">
<input type="hidden" name="static" value="1" />
<input type="hidden" name="entry_id" value="75380" />

<div id="name_email">
<p><label for="author">Name:</label><br />
<input tabindex="1" id="author" name="author" /></p>

<p><label for="email">Email Address:</label><br />
<input tabindex="2" id="email" name="email" /></p>
</div>



<p><label for="url">URL:</label><br />
<input tabindex="3" type="text" name="url" id="url" />
Remember Me?
<input type="radio" id="remember" onclick="rememberMe(this.form)" name="bakecookie" /><label for="remember">Yes</label><input type="radio" id="forget" name="bakecookie" onclick="forgetMe(this.form)" value="Forget Info" style="margin-left: 15px;" /><label for="forget">No</label><br style="clear: both;" />
</p>

<div class="quicktags"><p><label for="text">Comments:</label> </p>

<script src="http://www.movalog.com/mt/quicktags.js" type="text/javascript"></script><script type="text/javascript">edToolbar();</script>

<p><br style="clear: both;" />
<textarea tabindex="4" id="text" name="text" rows="10" cols="50"></textarea><script type="text/javascript">var edCanvas = document.getElementById('text');</script></p></div>


<div align="center">
<input type="submit" name="preview" tabindex="5" 
    value=" Preview " />
<input style="font-weight: bold;" type="submit" name="post" 
    tabindex="6" value=" Post " />
</div>
</form>




<script language="javascript" type="text/javascript" src="http://www.corante.com/js/comment_form.js"></script>






<!-- EMAIL THIS ENTRY -->

<a name="send"></a>
<form method="post" action="http://www.corante.com/cgi-bin/mt/mt-send-entry.cgi">
<input type="hidden" name="entry_id" value="75380" />
<input type="hidden" name="_redirect" value="http://pipeline.corante.com/archives/2012/01/17/down_with_the_research_works_act.php" />
<br />

<p><b>EMAIL THIS ENTRY TO A FRIEND</b></p>
<a name="zemail"></a>
Email this entry to:<br />
<input name="to" size="25" /><br />
Your email address:<br />
<input name="from" size="25" /><br />
Message (optional):<br />
<textarea name="message" rows="5" cols="30" wrap="virtual"></textarea>
<br />
<input type="submit" value="Send" />
</form>
<br />
<br />
<br />


<!-- RELATED ENTRIES -->

<dl>
<dt><b>RELATED ENTRIES</b></dt>

 
<dd>&#155; <a href="http://pipeline.corante.com/archives/2014/06/21/scripps_update.php">Scripps Update</a></dd>
 
<dd>&#155; <a href="http://pipeline.corante.com/archives/2014/06/20/what_if_drug_patents_were_written_like_software_patents.php">What If Drug Patents Were Written Like Software Patents?</a></dd>
 
<dd>&#155; <a href="http://pipeline.corante.com/archives/2014/06/20/stem_cells_the_center_of_right_to_try.php">Stem Cells: The Center of "Right to Try"</a></dd>
 
<dd>&#155; <a href="http://pipeline.corante.com/archives/2014/06/19/speaking_of_polyphenols_.php">Speaking of Polyphenols. . .</a></dd>
 
<dd>&#155; <a href="http://pipeline.corante.com/archives/2014/06/19/dark_biology_and_small_molecules.php">Dark Biology And Small Molecules</a></dd>
 
<dd>&#155; <a href="http://pipeline.corante.com/archives/2014/06/18/how_polyphenols_work_perhaps.php">How Polyphenols Work, Perhaps?</a></dd>
 
<dd>&#155; <a href="http://pipeline.corante.com/archives/2014/06/18/more_on_automated_medicinal_chemistry.php">More On Automated Medicinal Chemistry</a></dd>
 
<dd>&#155; <a href="http://pipeline.corante.com/archives/2014/06/17/scripps_merging_with_usc.php">Scripps Merging With USC?</a></dd>
 
</MTRelatedEntries>
</dl>


</div>
</div>
</td>


<td id="rlinks" valign="top">
<table cellspacing="0" cellpadding="0" border="0" width="190">
<tr>
<td>

<div class="tablead" style="background:#fff;font-size:100%;text-align:left">

<br /><br />
<div id="recent_entries">
<div class="sidetitle">RECENT ENTRIES</div>
<div class="rside">
<b>&#8250;</b> <a href="http://pipeline.corante.com/archives/2014/06/27/varieties_of_scientific_deception.php">Varieties of Scientific Deception</a><br /><br />
<b>&#8250;</b> <a href="http://pipeline.corante.com/archives/2014/06/26/absence_makes_the_ideas_flow.php">Absence Makes the Ideas Flow?</a><br /><br />
<b>&#8250;</b> <a href="http://pipeline.corante.com/archives/2014/06/26/alzheimers_bonds.php">Alzheimer's Bonds</a><br /><br />
<b>&#8250;</b> <a href="http://pipeline.corante.com/archives/2014/06/25/wheres_the_widest_variety_of_chemical_matter.php">Where's the Widest Variety of Chemical Matter?</a><br /><br />
<b>&#8250;</b> <a href="http://pipeline.corante.com/archives/2014/06/25/thats_just_too_colorful.php">That's Just Too Colorful</a><br /><br />
<b>&#8250;</b> <a href="http://pipeline.corante.com/archives/2014/06/25/zafgens_epoxide_pays_its_way.php">Zafgen's Epoxide Pays Its Way</a><br /><br />
<b>&#8250;</b> <a href="http://pipeline.corante.com/archives/2014/06/24/taking_risks_you_have_to_so_do_it_right.php">Taking Risks - You Have To, So Do It Right</a><br /><br />
<b>&#8250;</b> <a href="http://pipeline.corante.com/archives/2014/06/24/whoooeee.php">Whooo-eee</a><br /><br />
<b>&#8250;</b> <a href="http://pipeline.corante.com/archives/2014/06/23/go_home_gaijin.php">Go Home, Gaijin</a><br /><br />
<b>&#8250;</b> <a href="http://pipeline.corante.com/archives/2014/06/23/the_virtual_clinical_trial_not_quite_around_the_corner.php">The Virtual Clinical Trial: Not Quite Around the Corner</a><br /><br />

</div> 
</div>

<div class="sidetitle">RECENT COMMENTS <a href="http://pipeline.corante.com/25comments.xml"><span class="catxml">[xml]</span></a></div>
<div class="rside">
&#8250; yummy organic horse treats on <br /><a href="http://pipeline.corante.com/archives/2009/06/04/cafepharma_will_now_approach_the_bench.php#1502159">CafePharma Will Now Approach The Bench</a><br /><br />
&#8250; Anonymous BMS Researcher on <br /><a href="http://pipeline.corante.com/archives/2014/06/26/absence_makes_the_ideas_flow.php#1502140">Absence Makes the Ideas Flow?</a><br /><br />
&#8250; sepisp on <br /><a href="http://pipeline.corante.com/archives/2014/06/25/thats_just_too_colorful.php#1502103">That's Just Too Colorful</a><br /><br />
&#8250; Jared on <br /><a href="http://pipeline.corante.com/archives/2014/06/16/your_metal_azide_worries_are_over.php#1502058">Your Metal Azide Worries Are Over</a><br /><br />
&#8250; bob on <br /><a href="http://pipeline.corante.com/archives/2014/06/26/absence_makes_the_ideas_flow.php#1501714">Absence Makes the Ideas Flow?</a><br /><br />
&#8250; Anonymous on <br /><a href="http://pipeline.corante.com/archives/2014/06/27/varieties_of_scientific_deception.php#1501619">Varieties of Scientific Deception</a><br /><br />

</div>

<div id="archives">
<div class="sidetitle">&#8250; <a href="http://pipeline.corante.com/archives/cat_index.php">CATEGORIES</a></div>
<div id="category">
<div class="rside">
&#8250; <a href="http://pipeline.corante.com/archives/me_too_drugs/">"Me Too" Drugs (27)</a> <a href="http://pipeline.corante.com/archives/me_too_drugs.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/academia_vs_industry/">Academia (vs. Industry) (115)</a> <a href="http://pipeline.corante.com/archives/academia_vs_industry.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/aging_and_lifespan/">Aging and Lifespan (61)</a> <a href="http://pipeline.corante.com/archives/aging_and_lifespan.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/alzheimers_disease/">Alzheimer's Disease (79)</a> <a href="http://pipeline.corante.com/archives/alzheimers_disease.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/analytical_chemistry/">Analytical Chemistry (62)</a> <a href="http://pipeline.corante.com/archives/analytical_chemistry.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/animal_testing/">Animal Testing (29)</a> <a href="http://pipeline.corante.com/archives/animal_testing.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/autism/">Autism (23)</a> <a href="http://pipeline.corante.com/archives/autism.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/biological_news/">Biological News (198)</a> <a href="http://pipeline.corante.com/archives/biological_news.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/birth_of_an_idea/">Birth of an Idea (43)</a> <a href="http://pipeline.corante.com/archives/birth_of_an_idea.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/blink_8250/">Blink &#8250 (5)</a> <a href="http://pipeline.corante.com/archives/blink_8250.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/blog_housekeeping/">Blog Housekeeping (220)</a> <a href="http://pipeline.corante.com/archives/blog_housekeeping.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/book_recommenda/">Book Recommendations (26)</a> <a href="http://pipeline.corante.com/archives/book_recommendations.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/business_and_markets/">Business and Markets (769)</a> <a href="http://pipeline.corante.com/archives/business_and_markets.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/cancer/">Cancer (248)</a> <a href="http://pipeline.corante.com/archives/cancer.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/cardiovascular_disease/">Cardiovascular Disease (135)</a> <a href="http://pipeline.corante.com/archives/cardiovascular_disease.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/chembio_warfare/">Chem/Bio Warfare (15)</a> <a href="http://pipeline.corante.com/archives/chembio_warfare.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/chemical_biolog/">Chemical Biology (61)</a> <a href="http://pipeline.corante.com/archives/chemical_biology.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/chemical_news/">Chemical News (307)</a> <a href="http://pipeline.corante.com/archives/chemical_news.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/clinical_trials/">Clinical Trials (280)</a> <a href="http://pipeline.corante.com/archives/clinical_trials.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/closing_time/">Closing Time (17)</a> <a href="http://pipeline.corante.com/archives/closing_time.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/current_events/">Current Events (142)</a> <a href="http://pipeline.corante.com/archives/current_events.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/diabetes_and_obesity/">Diabetes and Obesity (120)</a> <a href="http://pipeline.corante.com/archives/diabetes_and_obesity.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/drug_assays/">Drug Assays (199)</a> <a href="http://pipeline.corante.com/archives/drug_assays.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/drug_development/">Drug Development (408)</a> <a href="http://pipeline.corante.com/archives/drug_development.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/drug_industry_history/">Drug Industry History (301)</a> <a href="http://pipeline.corante.com/archives/drug_industry_history.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/drug_prices/">Drug Prices (102)</a> <a href="http://pipeline.corante.com/archives/drug_prices.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/general_scientific_news/">General Scientific News (144)</a> <a href="http://pipeline.corante.com/archives/general_scientific_news.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/graduate_school/">Graduate School (58)</a> <a href="http://pipeline.corante.com/archives/graduate_school.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/how_not_to_do_it/">How Not to Do It (36)</a> <a href="http://pipeline.corante.com/archives/how_not_to_do_it.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/how_to_get_a_pharma_job/">How To Get a Pharma Job (28)</a> <a href="http://pipeline.corante.com/archives/how_to_get_a_pharma_job.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/in_silico/">In Silico (90)</a> <a href="http://pipeline.corante.com/archives/in_silico.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/infectious_diseases/">Infectious Diseases (123)</a> <a href="http://pipeline.corante.com/archives/infectious_diseases.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/inorganic_chemi/">Inorganic Chemistry (4)</a> <a href="http://pipeline.corante.com/archives/inorganic_chemistry.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/intelligent_design/">Intelligent Design (9)</a> <a href="http://pipeline.corante.com/archives/intelligent_design.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/job_postings/">Job Postings (1)</a> <a href="http://pipeline.corante.com/archives/job_postings.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/life_as_we_dont_know_it/">Life As We (Don't) Know It (20)</a> <a href="http://pipeline.corante.com/archives/life_as_we_dont_know_it.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/life_in_the_drug_labs/">Life in the Drug Labs (311)</a> <a href="http://pipeline.corante.com/archives/life_in_the_drug_labs.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/lowes_laws_of_the_lab/">Lowe's Laws of the Lab (7)</a> <a href="http://pipeline.corante.com/archives/lowes_laws_of_the_lab.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/metaphors_good/">Metaphors, Good and Bad (2)</a> <a href="http://pipeline.corante.com/archives/metaphors_good_and_bad.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/natural_product/">Natural Products (24)</a> <a href="http://pipeline.corante.com/archives/natural_products.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/odd_elements_in_drugs/">Odd Elements in Drugs (11)</a> <a href="http://pipeline.corante.com/archives/odd_elements_in_drugs.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/patents_and_ip/">Patents and IP (139)</a> <a href="http://pipeline.corante.com/archives/patents_and_ip.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/pharma_101/">Pharma 101 (12)</a> <a href="http://pipeline.corante.com/archives/pharma_101.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/pharmacokinetics/">Pharmacokinetics (50)</a> <a href="http://pipeline.corante.com/archives/pharmacokinetics.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/press_coverage/">Press Coverage (85)</a> <a href="http://pipeline.corante.com/archives/press_coverage.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/regulatory_affa/">Regulatory Affairs (152)</a> <a href="http://pipeline.corante.com/archives/regulatory_affairs.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/safety_warnings/">Safety Warnings (15)</a> <a href="http://pipeline.corante.com/archives/safety_warnings.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/science_gifts/">Science Gifts (11)</a> <a href="http://pipeline.corante.com/archives/science_gifts.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/snake_oil/">Snake Oil (67)</a> <a href="http://pipeline.corante.com/archives/snake_oil.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/the_central_nervous_system/">The Central Nervous System (123)</a> <a href="http://pipeline.corante.com/archives/the_central_nervous_system.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/the_dark_side/">The Dark Side (167)</a> <a href="http://pipeline.corante.com/archives/the_dark_side.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/the_scientific_literature/">The Scientific Literature (338)</a> <a href="http://pipeline.corante.com/archives/the_scientific_literature.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/things_i_wont_work_with/">Things I Won't Work With (29)</a> <a href="http://pipeline.corante.com/archives/things_i_wont_work_with.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/things_im_glad_i_dont_do/">Things I'm Glad I Don't Do (4)</a> <a href="http://pipeline.corante.com/archives/things_im_glad_i_dont_do.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/toxicology/">Toxicology (143)</a> <a href="http://pipeline.corante.com/archives/toxicology.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/who_discovers_and_why/">Who Discovers and Why (139)</a> <a href="http://pipeline.corante.com/archives/who_discovers_and_why.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>
&#8250; <a href="http://pipeline.corante.com/archives/why_everyone_loves_us/">Why  Everyone Loves Us (78)</a> <a href="http://pipeline.corante.com/archives/why_everyone_loves_us.xml"><span class="catxml">[xml]</span></a><br />
</MTCategories>

</div>
</div>

<div class="sidetitle">
&#8250; <a href="http://pipeline.corante.com/archives/date_index.php">ARCHIVES</a></div>
<div id="monthly">
<div class="rside">
&#8250; <a href="http://pipeline.corante.com/archives/2014/06/">June 2014 (42)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2014/05/">May 2014 (56)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2014/04/">April 2014 (39)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2014/03/">March 2014 (45)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2014/02/">February 2014 (42)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2014/01/">January 2014 (43)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2013/12/">December 2013 (41)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2013/11/">November 2013 (44)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2013/10/">October 2013 (50)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2013/09/">September 2013 (34)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2013/08/">August 2013 (42)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2013/07/">July 2013 (51)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2013/06/">June 2013 (39)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2013/05/">May 2013 (40)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2013/04/">April 2013 (46)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2013/03/">March 2013 (52)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2013/02/">February 2013 (45)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2013/01/">January 2013 (50)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2012/12/">December 2012 (39)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2012/11/">November 2012 (48)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2012/10/">October 2012 (42)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2012/09/">September 2012 (49)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2012/08/">August 2012 (38)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2012/07/">July 2012 (27)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2012/06/">June 2012 (37)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2012/05/">May 2012 (47)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2012/04/">April 2012 (31)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2012/03/">March 2012 (38)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2012/02/">February 2012 (46)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2012/01/">January 2012 (44)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2011/12/">December 2011 (35)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2011/11/">November 2011 (44)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2011/10/">October 2011 (35)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2011/09/">September 2011 (32)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2011/08/">August 2011 (37)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2011/07/">July 2011 (26)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2011/06/">June 2011 (35)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2011/05/">May 2011 (40)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2011/04/">April 2011 (31)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2011/03/">March 2011 (40)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2011/02/">February 2011 (27)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2011/01/">January 2011 (35)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2010/12/">December 2010 (34)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2010/11/">November 2010 (28)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2010/10/">October 2010 (39)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2010/09/">September 2010 (37)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2010/08/">August 2010 (38)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2010/07/">July 2010 (30)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2010/06/">June 2010 (42)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2010/05/">May 2010 (44)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2010/04/">April 2010 (48)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2010/03/">March 2010 (63)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2010/02/">February 2010 (36)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2010/01/">January 2010 (38)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2009/12/">December 2009 (25)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2009/11/">November 2009 (35)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2009/10/">October 2009 (30)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2009/09/">September 2009 (32)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2009/08/">August 2009 (27)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2009/07/">July 2009 (24)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2009/06/">June 2009 (40)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2009/05/">May 2009 (36)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2009/04/">April 2009 (24)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2009/03/">March 2009 (35)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2009/02/">February 2009 (33)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2009/01/">January 2009 (32)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2008/12/">December 2008 (17)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2008/11/">November 2008 (18)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2008/10/">October 2008 (24)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2008/09/">September 2008 (22)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2008/08/">August 2008 (15)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2008/07/">July 2008 (23)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2008/06/">June 2008 (20)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2008/05/">May 2008 (20)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2008/04/">April 2008 (22)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2008/03/">March 2008 (21)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2008/02/">February 2008 (20)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2008/01/">January 2008 (21)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2007/12/">December 2007 (15)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2007/11/">November 2007 (23)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2007/10/">October 2007 (23)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2007/09/">September 2007 (19)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2007/08/">August 2007 (21)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2007/07/">July 2007 (17)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2007/06/">June 2007 (12)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2007/05/">May 2007 (19)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2007/04/">April 2007 (23)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2007/03/">March 2007 (19)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2007/02/">February 2007 (27)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2007/01/">January 2007 (23)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2006/12/">December 2006 (16)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2006/11/">November 2006 (20)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2006/10/">October 2006 (24)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2006/09/">September 2006 (21)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2006/08/">August 2006 (19)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2006/07/">July 2006 (21)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2006/06/">June 2006 (24)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2006/05/">May 2006 (27)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2006/04/">April 2006 (20)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2006/03/">March 2006 (27)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2006/02/">February 2006 (21)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2006/01/">January 2006 (24)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2005/12/">December 2005 (21)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2005/11/">November 2005 (25)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2005/10/">October 2005 (26)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2005/09/">September 2005 (21)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2005/08/">August 2005 (29)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2005/07/">July 2005 (18)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2005/06/">June 2005 (24)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2005/05/">May 2005 (22)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2005/04/">April 2005 (18)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2005/03/">March 2005 (21)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2005/02/">February 2005 (21)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2005/01/">January 2005 (24)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2004/12/">December 2004 (24)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2004/11/">November 2004 (20)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2004/10/">October 2004 (23)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2004/09/">September 2004 (18)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2004/08/">August 2004 (21)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2004/07/">July 2004 (15)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2004/06/">June 2004 (19)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2004/05/">May 2004 (20)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2004/04/">April 2004 (20)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2004/03/">March 2004 (20)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2004/02/">February 2004 (23)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2004/01/">January 2004 (18)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2003/12/">December 2003 (1)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2003/11/">November 2003 (1)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2003/08/">August 2003 (1)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2003/01/">January 2003 (9)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2002/12/">December 2002 (24)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2002/11/">November 2002 (19)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2002/10/">October 2002 (26)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2002/09/">September 2002 (18)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2002/08/">August 2002 (18)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2002/07/">July 2002 (21)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2002/06/">June 2002 (12)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2002/05/">May 2002 (18)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2002/04/">April 2002 (9)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2002/03/">March 2002 (7)</a><br />
&#8250; <a href="http://pipeline.corante.com/archives/2002/02/">February 2002 (14)</a><br />

</div>
</div>
</div>


<div style="visibility: hidden">
<!--WEBBOT bot="HTMLMarkup" startspan ALT="Site Meter" -->
<script type="text/javascript" language="JavaScript">var site="s11corante"</script>
<script type="text/javascript" language="JavaScript1.2" src="http://s11.sitemeter.com/js/counter.js?site=s11corante">
</script>
<noscript>
<a href="http://s11.sitemeter.com/stats.asp?site=s11corante" target="_top">
<img src="http://s11.sitemeter.com/meter.asp?site=s11corante" alt="Site Meter" border="0" /></a>
</noscript>
<!-- Copyright (c)2002 Site Meter -->

<!--WEBBOT bot="HTMLMarkup" startspan ALT="Site Meter" -->
<script type="text/javascript" language="JavaScript">var site="sm8pipeline"</script>
<script type="text/javascript" language="JavaScript1.2" src="http://sm8.sitemeter.com/js/counter.js?site=sm8pipeline">
</script>
<noscript>
<a href="http://sm8.sitemeter.com/stats.asp?site=sm8pipeline" target="_top">
<img src="http://sm8.sitemeter.com/meter.asp?site=sm8pipeline" alt="Site Meter" border=0></a>
</noscript>
<!-- Copyright (c)2002 Site Meter -->
<!--WEBBOT bot="HTMLMarkup" Endspan -->

</div>
<br />
<br />
<a href="http://feeds.feedburner.com/InThePipeline"><img src="http://www.corante.com/frontpage/xml2.gif" border=0 /></a> 
<br />
<a href="http://feeds.feedburner.com/InThePipeline">
<img src="http://www.bloglines.com/images/sub_modern5.gif" border="0" alt="Subscribe with Bloglines" />
</a>
</div>
</div>

<!-- Start of StatCounter Code for Default Guide -->
<script type="text/javascript">
var sc_project=9776108; 
var sc_invisible=1; 
var sc_security="a99e4709"; 
var scJsHost = (("https:" == document.location.protocol) ?
"https://secure." : "http://www.");
document.write("<sc"+"ript type='text/javascript' src='" +
scJsHost+
"statcounter.com/counter/counter.js'></"+"script>");
</script>
<noscript><div class="statcounter"><a title="website
statistics" href="http://statcounter.com/"
target="_blank"><img class="statcounter"
src="http://c.statcounter.com/9776108/0/a99e4709/1/"
alt="website statistics"></a></div></noscript>
<!-- End of StatCounter Code for Default Guide --></td>
</tr>
</table>
</td>
</tr>
<tr>
<td colspan="3">
<table width="100%" cellpadding="0" cellspacing="0" border="0" id="footerbend">
<tr>
<td height="9"><img style="float:right;margin-right:-3px" src="http://www.corante.com/img/structural/footer_bottom_blue_t.gif" border="0" alt="" /></td>
</tr>
<tr>
<td height="140" id="footer" colspan="2">
<p>
<a href="http://www.corante.com/about.php">About Us</a> | 
<a href="http://www.corante.com/adinfo.php">Advertise</a> | 
<a href="http://www.corante.com/contact.php">Contact Us</a> | 
</p>
<p>
<a href="http://www.corante.com/privacy.php">Privacy Policy</a> | 
<a href="http://www.corante.com/terms.php">Terms of Use</a>
</p>
<p>&#169; Copyright 2006 Corante. All rights reserved. ()</p>
</td>
</tr>
</table>
</td>
</tr>
</table>
<!-- Resonance code resxclsa.js v2.x Copyright 2004-2006 Certona Corporation www.certona.com -->
<script language="JavaScript">
<!--
var resx = new Object();
resx.appid="corante01";
resx.top1=100000;
resx.top2=100000;
resx.lkmatch=/\/archives\/\d+\/\S+/i;
resx.rrec=false;
//-->
</script>
<script language="JavaScript" src="/YOURFOLDER/resxclsa.js"></script>
<!-- Resonance -->
</body>
</html>

